Robuta

https://www.medicalhalo.com/en/oncology/2550.html The most popular anti-cancer drug AMG510 enters clinical trials in China_Medicalhalo The AMG 510 drug developed by Amgen is an oral small molecule targeted drug targeting the KRAS G12C mutation. The most popular anti-cancer drug AMG510 has... clinical trials in chinathe most popular